Strategic Account Liaison (SAL), Rare Neurology - Northeast
Otsuka Pharmaceutical Co., Ltd.
Summary
The Strategic Account Liaison (SAL) is a field-based role responsible for supporting the launch and ongoing growth of Otsuka's Rare Neurology Franchise. The SAL will effectively communicate complex clinical data, protocols, screening and treatment pathways, market access policies, and patient support program information to ALS Centers of Excellence, health care providers, and key non-clinical stakeholders.
Job description
Responsibilities and Skills
- Understand complex disease states and quickly learn and articulate complex clinical data and outcomes.
- Educate on disease state awareness, screening and diagnostic pathways, and urgency to prioritize and treat appropriate patients.
- Identify, develop, and maintain relationships with HCPs and Key Opinion Leaders as a credible clinical resource.
- Create positive prescribing experience through clear articulation and pull-through of access and patient support programs.
- Participate in conferences, congresses, and scientific meetings to educate on rare neurology disease states and treatments.
- Develop strategic account plans by mining and connecting insights from diverse data sources, customer feedback, and market intelligence.
- Navigate and engage key stakeholders within ALS Centers of Excellence to understand roles, obtain contacts, capture process flows, and pull through objectives.
- Navigate complex treatment logistics, including site of care, patient onboarding, and therapy initiation barriers.
- Experience with hospital purchasing, coding, reimbursement procedures, and uncovering process flows within accounts.
- Partner with Market Access and Patient Support to compliantly remove barriers to therapy.
- Experience with products/disease states where the patient journey involves many physicians, specialties, and sites of care prior to diagnosis.
- Thrive without a highly prescriptive operating model to identify, validate, and document local referral networks for ALS.
- Map the patient journey, identify barriers to earlier recognition, specialist referral, genetic testing, genetic counseling, and connection to treatment-capable centers.
- Partner with cross-functional teammates such as Thought Leads Liaisons, Medical Science Liaisons, Case Managers, and Leadership.
- Proactively engage with others, support healthy discussions, read others' emotions, and adjust communication to drive alignment.
- Demonstrate tenacity and innovative thinking while collaboratively driving consensus among stakeholders.
- Leverage Otsuka platforms and technology to share account contact information, document IDN process flows, and community referral patterns.
- Enthusiastically engage in meetings and training programs to understand brand strategy, messaging, disease state, and customer engagement tactics.
- Certify on approved clinical resources, messaging, business acumen trainings, compliance, and Otsuka's policies.
Requirements
- Valid U.S. driver's license and driving record in compliance with company standards
- Bachelor's Degree Preferred
- 10+ (minimum 8) years of experience in Biotech/Pharma commercial field strategic roles
- Experience in new product launches
- Center of Excellence and IDN Navigation, including KOL engagement
- Rare and/or Ultra-Rare Disease experience
- Cross-functional field team coordination
- Background in rare neurology, CAR-T, Gene Therapy account management strongly preferred
- Advanced clinical degrees prioritized (BSN, RN, etc.) but not required
- Proven track record of success as demonstrated by consistent high ranking (Top 30%) over minimum 2+ years, achievement awards, etc.
- Must reside in Region
Benefits
- Medical, Dental & Vision
- Prescription Drug Coverage
- Basic Life Insurance
- AD&D Insurance
- Short-Term Disability
- Long-Term Disability
- Tuition Reimbursement
- Student Loan Assistance
- 401(k) Matching
- Flexible Time Off
- Paid Holidays
- Paid Leave Programs
Company overview
Otsuka Pharmaceutical Co., Ltd. is a leading Japanese pharmaceutical company headquartered in Tokyo, Japan. Founded on August 10, 1964, the company operates as a wholly owned subsidiary of Otsuka Holdings Co., Ltd. With approximately 5,907 employees as of December 2024, Otsuka Pharmaceutical specializes in the research, development, manufacturing, and marketing of pharmaceutical products, clinical testing equipment, medical devices, food products, and cosmetics. The company has established a strong global presence with operations spanning multiple countries and regions. Otsuka is particularly known for its innovative approach to healthcare, focusing on both pharmaceutical treatments and nutraceutical products that support everyday health maintenance. The company's diverse portfolio includes well-known brands and has made significant contributions to various therapeutic areas, demonstrating its commitment to improving global health through scientific innovation and quality healthcare solutions.